Count | |
| 2 | |
| 5 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 2 | |
| 1 | |
Prednisolone/adverse effects/antagonists & inhibitors/*therapeutic use | 1 |
Prednisolone/administration & dosage/adverse effects/*pharmacology | 1 |
| 1 | |
| 86 | |
| 22 | |
| 9 | |
| 2 | |
| 1 | |
| 19 | |
| 70 | |
| 3 | |
| 12 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 4 | |
| 1 | |
| 2 | |
| 1 | |
Prednisolone/*analogs & derivatives/metabolism/pharmacokinetics | 1 |
| 1 | |
Prednisolone/administration & dosage/*pharmacology/therapeutic use | 1 |
Prednisolone/administration & dosage/pharmacokinetics/therapeutic use | 1 |
Arginine/adverse effects/*analogs & derivatives/blood/*drug effects | 1 |
C-Reactive Protein/adverse effects/*drug effects/*metabolism | 1 |
Phosphoproteins/adverse effects/*antagonists & inhibitors/drug effects | 1 |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 4 | |
| 2 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 5 | |
| 5 | |
| 4 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 3 | |
| 10 | |
| 4 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 11 | |
| 1 | |
| 10 | |
| 1 | |
| 1 | |
| 1 | |
| 7 | |